StockData
HUTCHMED (China) Ltd logo

HUTCHMED (China) Ltd (HCM) stock

HCMNasdaqPharmaceutical PreparationsAlso trades as HMDCF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 5, 2026Score 5/30
$14.40−0.33 (-2.24%)

Close on Nov 17, 2026Market cap $2.51BP/E 5.5Yield –

HUTCHMED (China) price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

HUTCHMED (China)'s price to sales ratio was 4.8× on Nov 11, 2026, against 4.0× a year earlier. Over the last 5 years it ranged from 2.8× to 21.5×, with a median of 4.4×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20264.8×+1.1
2025Dec 31, 20253.7×+0.7
2024Dec 31, 20243.0×−4.2
2023Dec 29, 20237.2×+0.6
2022Dec 30, 20226.6×−14.9
2021Dec 31, 202121.5×+0.7
2020Dec 31, 202020.8×+4.5
2019Dec 31, 201916.3×+4.5
2018Dec 31, 201811.8×−10.1
2017Dec 29, 201721.9×+13.6
2016Dec 30, 20168.3×–

More HUTCHMED (China) figures

See a number that looks wrong?